Congenital thrombotic thrombocytopenic purpura

From - A Hematology Oncology Wiki
Jump to navigation Jump to search

Section editor
Tillman Benjamin-2.jpg
Benjamin Tillman, MD
Vanderbilt University
Nashville, TN, USA

  • We have moved How I Treat articles to a dedicated page.
1 regimens on this page
1 variants on this page

All lines of therapy

rADAMTS13 monotherapy


Study Dates of enrollment Evidence Comparator Comparative Efficacy
Scully et al. 2024 (cTTP) 2010-10 to 2014-01 Phase 3 (E-switch-ooc) Standard treatment No acute TTP events

Supportive therapy


  1. cTTP: Scully M, Antun A, Cataland SR, Coppo P, Dossier C, Biebuyck N, Hassenpflug WA, Kentouche K, Knöbl P, Kremer Hovinga JA, López-Fernández MF, Matsumoto M, Ortel TL, Windyga J, Bhattacharya I, Cronin M, Li H, Mellgård B, Patel M, Patwari P, Xiao S, Zhang P, Wang LT; cTTP Phase 3 Study Investigators. Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura. N Engl J Med. 2024 May 2;390(17):1584-1596. link to original article PubMed NCT03393975